From: Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p
Clinicopathologic parameters
Case
Age (years)
 ≤ 60
12
 > 60
18
Tumor size
  ≤ 2.5 cm
20
  > 2.5 cm
10
Pathological stage
 I–II
19
 III
11
Lymph node metastasis
 No
9
 Yes
21
Histological grade
 G1 + G2
16
 G3
14